Featured Dataverses

In order to use this feature you must have at least one published or linked dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

31 to 40 of 113 Results
8_HPRIME_Form8_SAE_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 47.4 KB - MD5: 689cb173d017ee29508f301aa34397d1
99_HPRIME_Form99_Additional information_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 24.5 KB - MD5: c223b276287d2377adc584854aaba914
9A_HPRIME_Form9A_research haematology_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 36.4 KB - MD5: ab64cdf70d0d83f39d28a4d2b1abbbf7
9B_HPRIME_Form9B_research haematology_v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 39.7 KB - MD5: 194004cf69853f6693ec7e7f403c2884
H-PRIME CRFs summary of changes 20241218.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 21.8 KB - MD5: f304cfa2ffe8cb1e3872c71bacb0032d
Source document A Locator details v3.0_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 22.3 KB - MD5: b844dec94712fe1818cc64b0cb830008
Source document B_clinic notes v2.7.1_20241218_clean.docx
May 2, 2025 - Extended Data for: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 23.4 KB - MD5: 90a86d37f15d6d8e8955592aab92c601
SPIRIT-Checklist_H-PRIME_220425.doc
Apr 23, 2025 - SPIRIT 2013 Checklist: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 122.0 KB - MD5: e427a3444f48a2a15978760a62f6f608
SPIRIT Checklist
H-PRIME Trial Assessment Schedule.docx
Apr 22, 2025 - SPIRIT 2013 Checklist: Hydroxyurea - Pragmatic Reduction In Mortality and Economic burden (H-PRIME): A 2x2x2 factorial randomised open-label trial investigating practical approaches to the treatment of sickle cell disease at four sites in Eastern Uganda: ISRCTN 15724013
MS Word - 37.2 KB - MD5: 090d0ad3b7bccc9063c61531f60253a1
Trial Assessment Schedule
Replication Data for: Non-O ABO blood group genotypes differ in their associations with Plasmodium falciparum rosetting and severe malaria
Jun 2, 2023
Opi, Herbert; Ndila, Carolyne M.; Uyoga, Sophie; Macharia, Alex W.; Fennell,Clare; Ochola, Lucy B.; Nyutu,Gideon; Siddondo,Bethsheba R.; Ojal, John; Shebe, Mohammed; Awuondo, Kennedy O.; Mturi, Neema; Peshu, Norbert; Tsofa, Benjamin; Band, Gavin; Maitland, Kathryn; Kwiatkowski, Dominic P.; Rockett, Kirk A.; Williams, Thomas N.; Rowe, J. Alexandra, 2023, "Replication Data for: Non-O ABO blood group genotypes differ in their associations with Plasmodium falciparum rosetting and severe malaria", https://doi.org/10.7910/DVN/A5KILM, Harvard Dataverse, V1
We present here the replication dataset used to generate results for the manuscript titled "Non-O ABO blood group genotypes differ in their associations with Plasmodium falciparum rosetting and severe malaria". The dataset included here comprise of clinical, epidemiological and multiple host genotype (including ABO blood group) data from a cases co...
Add Data

Sign up or log in to create a dataverse or add a dataset.

Sign Up Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.